- Approval Id
- 10b521ae2a2beb6a
- Drug Name
- ZYMAR OPHTHALMIC SOLUTION 0.3%
- Product Name
- ZYMAR OPHTHALMIC SOLUTION 0.3%
- Approval Number
- SIN12612P
- Approval Date
- 2004-11-05
- Registrant
- ABBVIE PTE. LTD.
- Licence Holder
- ABBVIE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- SOLUTION
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong></p>
<p>The recommended dosage regimen for the treatment of bacterial conjunctivitis is:</p>
<p>Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.</p>
<p>Days 3 through 7: Instill one drop up to four times daily while awake.</p>
- Route Of Administration
- OPHTHALMIC
- Indication Info
- <p><strong>INDICATIONS AND USAGE</strong></p>
<p>ZYMAR® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:</p>
<table class="borderless-100">
<tbody>
<tr>
<td colspan="2" rowspan="1"><strong>Aerobic Gram-Positive Bacteria:</strong></td>
</tr>
<tr>
<td><em>Cornyebacterium propinquum*</em></td>
<td><em>Streptococcus mitis*</em></td>
</tr>
<tr>
<td><em>Staphylococcus aureus</em></td>
<td><em>Streptococcus pneumoniae</em></td>
</tr>
<tr>
<td colspan="2" rowspan="1"><em>Staphylococcus epidermidis</em><br><br></td>
</tr>
<tr>
<td colspan="2" rowspan="1"><strong>Aerobic Gram-Negative Bacteria:</strong></td>
</tr>
<tr>
<td colspan="2" rowspan="1"><em>Haemophilus influenzae</em></td>
</tr>
</tbody>
</table>
<p>* Efficacy for this organism was studied in fewer than 10 infections.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong></p>
<p>ZYMAR® solution is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.</p>
- Atc Code
- S01AX21
- Atc Item Name
- xs 01 ax 21
- Pharma Manufacturer Name
- ABBVIE PTE. LTD.
- Company Detail Path
- /organization/abbvie-pte-ltd
